KUALA LUMPUR, Aug 19 — KPJ Healthcare Bhd’s shares rose 3.97 per cent in early trade on Wednesday after it reported a 27 per cent rise in net profit for the second quarter ended June 30, 2026 (2Q FY2026).
At 10.21 am, its shares were up 12 sen at RM3.14, with 13.46 million shares traded.
The private healthcare provider’s net profit rose to RM103.92 million in 2Q FY2026 from RM82.06 million a year earlier, while revenue increased 17 per cent to RM1.20 billion from RM1.02 billion, driven by higher patient activity and more complex treatments.
Surgeries increased 12 per cent, inpatient admissions rose 10 per cent, while average revenue per patient grew seven per cent across inpatient and outpatient services.
In a note, Public Investment Bank Bhd said the results were broadly in line with its and consensus expectations, accounting for 46 per cent and 44 per cent of full-year forecasts, respectively.
It expects hospital activity to strengthen in the second half of FY2026 and remains cautiously optimistic about KPJ’s growth prospects, supported by sustained demand for quality healthcare.
“Meanwhile, the introduction of MediASAS as part of the government’s healthcare financing reforms could improve affordability and accessibility to private healthcare services.
“As such, we maintain our FY2026-2028 earnings forecasts and reiterate our ‘neutral’ rating on KPJ, with an unchanged target price of RM3.17,” it said.
Meanwhile, CIMB Securities Sdn Bhd said KPJ should be able to sustain positive inpatient revenue intensity growth, supported by its hospital upscaling programme as it works to establish 15 centres of excellence across its hospital network by 2030.
The initiative would further strengthen KPJ’s focus on sub-speciality procedures, it said.
“With the 2Q FY2026 results in line with our expectations, we make no changes to our core net profit estimates.
“We maintain our ‘buy’ rating on KPJ, with a target price of RM4.09,” it said.
